Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge

<div>The fluctuation of liver and kidney function indicators before and after esophageal tumor treatment. ALT: alanine aminotransferase; AST: aspartate transaminase; <i>γ</i>-GT: glutamyl transpeptidase; ALP: alkaline phosphatase; Cr: creatinine.</div>

Journal of Immunology Research

fig8

Figure 8

Figure 8: Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge 

Figure 8 | Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge 